TotalMarketCap

Amneal Pharmaceuticals

AMRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$6.776 B

$19.46 -2.48%

Close of 6 Nov 2026

As of 6 Nov 2026, Amneal Pharmaceuticals (AMRX) has a market capitalization of $6.78B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.02B

#911 by revenue

Earnings

$72.1M

#1423 by earnings

Shares outstanding

319,353,919

Latest filing cover page

P/E ratio

94.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #44Kiniksa Pharmaceuticals InternationalKNSA$6.95B
  2. #45Axsome TherapeuticsAXSM$6.80B
  3. #46Amneal PharmaceuticalsAMRX$6.78B
  4. #47Ionis PharmaceuticalsIONS$6.43B
  5. #48Mirum PharmaceuticalsMIRM$6.11B

What if Amneal Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$81,071.48

Per share 4,167× higher

Bitcoin $1.53T

$4,386.64

Per share 225× higher

Apple $5.02T

$14,400.92

Per share 740× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Amneal Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.